FDA Inspection 1120152 — Anand Multispeciality Hospital and Research Centre
The FDA completed an inspection of Anand Multispeciality Hospital and Research Centre on March 6, 2020 in Gandhinagar. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 6, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Gandhinagar (India)
Additional Details
Clinical BA/BE